Progyny, Inc. (NASDAQ:PGNY), a leading provider of fertility and family building benefits with a market capitalization of $1.76 billion, has been navigating a complex market landscape characterized by ...

This drop was disheartening since the S&P 500 held its ground. Progyny has been on fire lately. In the past six months alone, the company’s stock price has rocketed 53.8%, reaching $21.50 per share.

Progyny is a leading benefits management company specializing in fertility and family building solutions. It serves a significant but underserved market through unique plan designs, coordinated ...

There’s a whole lot to admire in this project. The swing-out transparent OLED display is super slick, the electronics are housed on a single PCB, the back half of the grip is in fact a portable ...

Looking back on health insurance providers stocks’ Q1 earnings, we examine this quarter’s best and worst performers, including Progyny (NASDAQ:PGNY) and its peers. UnitedHealth (UNH ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

CVS' diverse operations create the opportunity to view a patient more holistically by managing both medical and pharmacy benefits, which could lead to revenue and cost synergies for the ...

At close: 27 May at 4:00:00 pm GMT-4 ...